Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Eir Ventures is a Nordic life sciences venture capital fund established to finance the development of innovative medicine. Founded in 2018, the firm operates from its offices in Stockholm, Sweden, and Copenhagen, Denmark. Eir Ventures focuses on investing in companies and entrepreneurs that are developing transformative healthcare solutions. The firm has built a reputation for its commitment to advancing healthcare innovation through strategic investments.
Currently, Eir Ventures manages a portfolio of eight companies, reflecting its targeted approach to the life sciences sector. The founding team comprises experienced professionals with MD and PhD qualifications, enhancing their expertise in evaluating and supporting life science ventures. The firm aims to balance lower-risk investments with high-potential innovations, contributing to the growth of the healthcare industry in the Nordics and beyond.
Eir Ventures invests in high-potential life science opportunities, targeting both early-stage projects and more mature companies. Their investment strategy encompasses pre-seed and seed stage investments, as well as Series A funding, allowing them to engage with startups at various stages of development. The firm emphasizes transformative potential, excellence in execution, and scalability in its portfolio companies.
Geographically, Eir Ventures focuses on Europe, particularly the Nordics, where they identify and support innovative healthcare solutions. The firm seeks to partner with entrepreneurs who demonstrate a strong vision and capability to execute their ideas. Eir Ventures aims to balance lower-risk investments with high-potential innovations, ensuring a diversified portfolio that can adapt to the evolving healthcare landscape.
Eir Ventures has made several notable investments in the life sciences sector, including:
This diverse portfolio showcases Eir Ventures' commitment to advancing healthcare solutions through strategic investments in innovative companies.
Magnus Persson, Founding Partner, MD, PhD, Associate Professor. Magnus has extensive experience in the life sciences sector and has led numerous successful investments in healthcare.
Amanda Hayward, Founding Partner, PhD. Amanda brings a strong academic background and expertise in biotech, contributing to the firm's investment strategy.
Stephan Christgau, Founding Partner, PhD. Stephan has a deep understanding of the healthcare landscape and plays a key role in evaluating investment opportunities.
Tobias Horneman-Thielcke, Partner, MD, LLB. Tobias combines legal expertise with medical knowledge, enhancing the firm's due diligence process.
Lovisa Backemar, Partner, MD, PhD. Lovisa's clinical background and research experience inform the firm's investment decisions in life sciences.
Submit your pitch through their website's contact form at [URL]. Ensure your proposal highlights the transformative potential of your healthcare solution.
What are Eir Ventures' investment criteria?
Eir Ventures focuses on high-potential life science opportunities, particularly in biotech and healthcare. They invest in pre-seed, seed, and Series A stages, targeting companies that demonstrate transformative potential and scalability.
How can startups apply or pitch to Eir Ventures?
Startups interested in pitching to Eir Ventures should prepare a comprehensive deck that outlines their business model, market opportunity, and team qualifications. They can reach out through the firm's website for further instructions on the application process.
What makes Eir Ventures different from other venture capital firms?
Eir Ventures distinguishes itself through its focus on the life sciences sector and its commitment to supporting transformative healthcare solutions. The firm combines deep industry expertise with a strategic investment approach to foster innovation.
What is the geographic scope of Eir Ventures' investments?
Eir Ventures primarily invests in Europe, with a strong emphasis on the Nordic region. They seek to identify and support innovative healthcare solutions within this geographic focus.
What is Eir Ventures' post-investment involvement like?
Eir Ventures actively engages with its portfolio companies, providing operational support, mentorship, and access to their extensive network in the life sciences sector. They aim to help startups navigate challenges and scale effectively.
What is the typical check size for investments made by Eir Ventures?
While specific check sizes are not disclosed, Eir Ventures invests across pre-seed, seed, and Series A stages, indicating a flexible approach to funding based on the needs of the portfolio companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.